Advertisement

NCCN Guidelines for the Management of Immunotherapy-Related Toxicities (Version 1.2022)
Posted: 04/26/2022 | By: Sarah Campen, PharmD

Question 1 of 5

Which of the following actions are NOT recommended by the NCCN panel post–CAR T-cell infusion?

Choose 1

A
Complete blood count, complete metabolic panel, and coagulation profiles should be monitored daily post-infusion
B
C-reactive protein and serum ferritin should be rechecked at least daily for 2 weeks post-infusion
C
Seizure prophylaxis should be continued for 4 weeks following infusion
D
Neurotoxicity assessment should be done at least twice daily, or when a patient’s status changes

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage